CD69 (Cluster of Differentiation 69) is a human transmembrane C-Type lectinprotein encoded by the CD69gene.
The activation of T lymphocytes and Natural Killer (NK) Cells, both in vivo and in vitro, induces expression of CD69. This molecule, which appears to be the earliest inducible cell surface glycoprotein acquired during lymphoid activation, is involved in lymphocyte proliferation and functions as a signal-transmitting receptor in lymphocytes, including natural killer (NK) cells, and platelets (Cambiaggi et al., 1992) [supplied by OMIM].[1]
Cambiaggi C, Scupoli MT, Cestari T, et al. (1992). "Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12". Immunogenetics. 36 (2): 117–20. doi:10.1007/BF00215288. PMID1612643.
López-Cabrera M, Muñoz E, Blázquez MV, et al. (1995). "Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements". J. Biol. Chem. 270 (37): 21545–51. doi:10.1074/jbc.270.37.21545. PMID7665567.
Bezouska K, Nepovím A, Horváth O, et al. (1995). "CD 69 antigen of human lymphocytes is a calcium-dependent carbohydrate-binding protein". Biochem. Biophys. Res. Commun. 208 (1): 68–74. doi:10.1006/bbrc.1995.1306. PMID7887967.
Santis AG, López-Cabrera M, Hamann J, et al. (1994). "Structure of the gene coding for the human early lymphocyte activation antigen CD69: a C-type lectin receptor evolutionarily related with the gene families of natural killer cell-specific receptors". Eur. J. Immunol. 24 (7): 1692–7. doi:10.1002/eji.1830240735. PMID8026529.
Ziegler SF, Ramsdell F, Hjerrild KA, et al. (1993). "Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens". Eur. J. Immunol. 23 (7): 1643–8. doi:10.1002/eji.1830230737. PMID8100776.
Hamann J, Fiebig H, Strauss M (1993). "Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain". J. Immunol. 150 (11): 4920–7. PMID8496594.
Krowka JF, Cuevas B, Maron DC, et al. (1996). "Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals". J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11 (1): 95–104. doi:10.1097/00042560-199601010-00013. PMID8528739.
Vance BA, Bennett MJ, Ward Y, et al. (1999). "Distinct but dispensable N-glycosylation of human CD69 proteins". Arch. Biochem. Biophys. 368 (2): 214–20. doi:10.1006/abbi.1999.1322. PMID10441371.
Blázquez MV, Macho A, Ortiz C, et al. (1999). "Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins". AIDS Res. Hum. Retroviruses. 15 (13): 1209–18. doi:10.1089/088922299310304. PMID10480634.
Llera AS, Viedma F, Sánchez-Madrid F, Tormo J (2001). "Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69". J. Biol. Chem. 276 (10): 7312–9. doi:10.1074/jbc.M008573200. PMID11036086.
Natarajan K, Sawicki MW, Margulies DH, Mariuzza RA (2001). "Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells". Biochemistry. 39 (48): 14779–86. doi:10.1021/bi0018180. PMID11101293.
Liu X, Schrager JA, Lange GD, Marsh JW (2001). "HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations". J. Biol. Chem. 276 (35): 32763–70. doi:10.1074/jbc.M101025200. PMID11438519.
Yoshimura C, Yamaguchi M, Iikura M, et al. (2002). "Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3". J. Allergy Clin. Immunol. 109 (5): 817–23. doi:10.1067/mai.2002.123532. PMID11994706.
Pisegna S, Zingoni A, Pirozzi G, et al. (2002). "Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells". J. Immunol. 169 (1): 68–74. doi:10.4049/jimmunol.169.1.68. PMID12077230.
Liu CC, Huang KJ, Lin YS, et al. (2002). "Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection". J. Med. Virol. 68 (2): 241–52. doi:10.1002/jmv.10198. PMID12210415.
Foerster M, Haefner D, Kroegel C (2002). "Bcl-2-mediated regulation of CD69-induced apoptosis of human eosinophils: identification and characterization of a novel receptor-induced mechanism and relationship to CD95-transduced signalling". Scand. J. Immunol. 56 (4): 417–28. doi:10.1046/j.1365-3083.2002.01111.x. PMID12234263.
Weigel G, Griesmacher A, Karimi A, et al. (2003). "Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients". J. Heart Lung Transplant. 21 (10): 1074–9. doi:10.1016/S1053-2498(02)00440-0. PMID12398872.